NCT07433764 Test-Retest Reliability of the WB6Dim Digital Well-Being Tool: A 3-Day Interval Study
| NCT ID | NCT07433764 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Clover Link |
| Condition | Psychological Well Being |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2026-02-19 |
| Primary Completion | 2026-02-22 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2026-02-19 with a primary completion date of 2026-02-22.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to establish the test-retest reliability of the WB6Dim digital self-assessment tool across its eight well-being dimensions, using a 3-day interval protocol designed to minimize the probability of genuine well-being changes between assessments. Participants complete the 28-item WB6Dim questionnaire at baseline (T1) and again 3 days later (T2). A single contamination control question at T2 identifies participants who experienced a significant life event during the interval; these pairs are excluded from primary ICC analyses and retained for exploratory analyses. An optional third assessment at 9 weeks (T3) provides preliminary exploratory data on sensitivity to change following access to a well-being program. T3 is not part of the primary design.
Eligibility Criteria
Inclusion Criteria: * Adults aged 18 years or older * Able to read and understand French * Access to an internet-connected device * Willing to complete the WB6Dim questionnaire at T1 and T2 * Consent to anonymous data collection for research purposes Exclusion Criteria: * Under 18 years of age * Unable to read or understand French
Contact & Investigator
Frédérique MD, PhD RETORNAZ, MD, PhD
STUDY CHAIR
European Hospital, Unit of Care and Research in Internal Medicine and Infectious Diseases.
Frequently Asked Questions
Who can join the NCT07433764 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Psychological Well Being. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07433764 currently recruiting?
Yes, NCT07433764 is actively recruiting participants. Contact the research team at quentin.alitta@gmail.com for enrollment information.
Where is the NCT07433764 trial being conducted?
This trial is being conducted at Bandol, France.
Who is sponsoring the NCT07433764 clinical trial?
NCT07433764 is sponsored by Clover Link. The principal investigator is Frédérique MD, PhD RETORNAZ, MD, PhD at European Hospital, Unit of Care and Research in Internal Medicine and Infectious Diseases.. The trial plans to enroll 500 participants.